World Wires · story 5404 · unverified · 1 source(s)

Atossa Therapeutics Plans to Issue Stapled CVR for Shareholders

Atossa Therapeutics announced plans to issue contingent value rights tied to a potential rare pediatric disease priority review voucher.

Open in the desk

Coverage

What this site indexes